LEADER 01586nam  2200409Ia 450 
001 9910698720703321
005 20090424144639.0
035   $a(CKB)5470000002396652
035   $a(OCoLC)319172582
035   $a(EXLCZ)995470000002396652
100   $a20090424d2008      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $ecertain human cells, tissues and cellular and tissue-based products (HCT/Ps) recovered from donors who were tested for communicable diseases using pooled speciments or diagnostic tests
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[2008]
215   $ai, 8 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on Apr. 24, 2009).
300   $a"April 2008".
517   $aGuidance for industry 
606   $aDonation of organs, tissues, etc
606   $aCommunicable diseases$xDiagnosis
606   $aCommunicable diseases$xPrevention
606   $aDiagnostic specimens
615  0$aDonation of organs, tissues, etc.
615  0$aCommunicable diseases$xDiagnosis.
615  0$aCommunicable diseases$xPrevention.
615  0$aDiagnostic specimens.
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698720703321
996   $aGuidance for industry$93434577
997   $aUNINA